BCL2 and non-small cell lung carcinoma: Interestingly, while a p53 gene mutation correlated with poor survival in NSCLC patients, sole Bcl-2 abnormalities showed no significant influence on the prognosis, consorting with our findings that isolated Bcl-2 inhibition had no impact on our NSCLC cell lines’ vitality [23].